2019 Annual Meeting | C141 - Rehabilitation in Neurology

��ɫ��

2019 Annual Meeting | C141 - Rehabilitation in Neurology

Date Tuesday 05/07/19

Time 01:00 PM - 03:00 PM EDT Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Marc W. Slutzky, MD, PhD, FAAN

Topic(s) Neuro-rehabilitation

Learning Objectives Participants should be able to develop a greater understanding of the multidisciplinary care of patients with disability from neurologic diseases, as well as develop understanding of the current research for improving care.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge

Program Level Intermediate

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist

Teaching Styles Didactic

Program Materials Program Evaluations

Event Timeline
01:00 PM - 01:05 PM EDT	Introduction	Rehabilitation in Neurology Marc W. Slutzky, MD, PhD, FAAN
01:05 PM - 01:35 PM EDT	Speaker	Brain Repair After Stroke Steven C. Cramer, MD, FAAN
01:35 PM - 01:40 PM EDT	Q&A	Questions and Answers Steven C. Cramer, MD, FAAN
01:40 PM - 02:10 PM EDT	Speaker	Rehabilitation of Spinal Cord Injury An Hong Do, MD
02:10 PM - 02:15 PM EDT	Q&A	Questions and Answers An Hong Do, MD
02:15 PM - 02:45 PM EDT	Speaker	Neurotechnology in Rehabilitation Marc W. Slutzky, MD, PhD, FAAN
02:45 PM - 02:50 PM EDT	Q&A	Questions and Answers Marc W. Slutzky, MD, PhD, FAAN
02:50 PM - 03:00 PM EDT	Discussion	Panel Discussion

Faculty Disclosures
Marc W. Slutzky, MD, PhD, FAAN	No disclosure on file
An Hong Do, MD	Dr. Do has nothing to disclose.
Steven C. Cramer, MD, FAAN	Dr. Cramer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Constant Therapeutics, BrainQ, Myomo, MicroTransponder, Panaxium, Beren Therapeutics, Medtronic, Stream Biomedical, NeuroTrauma Sciences, and TRCare. . Dr. Cramer has stock in Constant Therapeutics, Panaxium, and TRCare. The institution of Dr. Cramer has received research support from NIH; PCORI; Veterans Administration.

��ɫ����

��ɫ����

��ɫ��

��ɫ��